Investigating eosinophilia
- PMID: 36737076
- DOI: 10.1136/bmj-2022-070295
Investigating eosinophilia
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: JL has received payments from Kite Gilead (for work on advisory boards on the treatment of mantle cell lymphoma and conference registration fees) and from Takeda (conference registration fees). As far as we are aware, neither pharmaceutical company has an interest in eosinophilia. Further details of The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical